Fund Overview of Nippon India Pharma Fund Direct-IDCW
-
₹9,166.4 CrAUM
-
₹175.42NAV
-
0.99%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Nippon India Pharma Fund Direct-IDCW Return Comparison
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | -0.10% | NA | 6.12% |
| 6 Months | 9.28% | NA | 12.92% |
| 1 Year | 10.92% | 10.92% | 6.04% |
| 2 Years | 13.04% | 6.32% | 24.93% |
| 3 Years | 68.34% | 18.96% | 25.71% |
| 5 Years | 97.57% | 14.59% | 19.91% |
| 7 Years | 308.13% | 22.25% | NA |
| 10 Years | 344.38% | 16.08% | 12.78% |
Dividends are declared by the fund house based on the income generated from the underlying assets. While many mutual funds distribute dividends annually, the payout frequency ultimately depends on the fund house’s decision
Asset Allocation of Nippon India Pharma Fund Direct-IDCW
equities
97.99%debt instruments
0.01%other assets or cash equivalents
2.00%Nippon India Pharma Fund Direct-IDCW is one Equity mutual fund offered by Nippon India Mutual Fund. Launched on 01 Jan 2013, the fund aims Long term capital growth. Investment in equity and equity related Securities of pharma & other associated companies. It manages assets worth ₹9,166.4 crore as on Wed Sep 30, 2026. The expense ratio stands at 0.99%. Fund Manager Manager EducationAbout Nippon India Pharma Fund Direct-IDCW
The portfolio allocation consists of 97.99% in equities, 0.01% in debt instruments, 2.00% in other assets or cash equivalents.Managed by Sailesh Raj Bhan, it has delivered a return of 10.92% in the last year, a total return since inception of 17.36%.
The latest dividend was declared on 06 Feb 2026 at 120.00% of face value.
To make better financial choices it is useful to also explore best sip plans suited to individual risk appetite.
Key Metrics of Nippon India Pharma Fund Direct-IDCW
-
Standard Deviation14.87%
-
Mean18.37%
-
Sharpe Ratio0.86%
-
Alpha-2.14%
-
Beta0.89%
-
Sortino Ratio1.30%
Nippon India Pharma Fund Direct-IDCW Fund Details
|
|
Compare Nippon India Pharma Fund Direct-IDCW with other mutual funds in the same category
Nippon India Pharma Fund Direct-IDCW
SBI Healthcare Opportunities Fund Direct Plan-Growth
SBI Healthcare Opportunities Fund Direct Plan-IDCW
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-Growth |
₹5,870 | 4.94% | 1.38% | 20.99% | 25.46% | 19.69% |
| SBI Healthcare Opportunities Fund Direct Plan-IDCW |
₹5,870 | 4.94% | 1.38% | 20.99% | 25.46% | 19.69% |
| SBI Healthcare Opportunities Fund-Growth |
₹5,870 | 4.85% | 1.13% | 19.79% | 24.17% | 18.45% |
| SBI Healthcare Opportunities Fund-IDCW |
₹5,870 | 4.85% | 1.13% | 19.79% | 24.17% | 18.45% |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹6,861 | 3.40% | -1.15% | 7.63% | 22.70% | 17.19% |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹6,861 | 3.40% | -1.15% | 7.63% | 22.70% | 17.19% |
| Mirae Asset Healthcare Fund Direct-Growth |
₹3,494 | 5.10% | 3.09% | 22.03% | 24.58% | 17.02% |
| Mirae Asset Healthcare Fund Direct-IDCW |
₹3,494 | 5.10% | 3.09% | 22.03% | 24.58% | 17.02% |
| UTI Healthcare Fund Direct-Growth |
₹1,430 | 3.56% | 0.97% | 17.27% | 24.39% | 16.87% |
| UTI Healthcare Fund Direct-IDCW |
₹1,430 | 3.56% | 0.97% | 17.27% | 24.39% | 16.87% |
More funds from Nippon India Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Nippon India Pharma Fund Direct-Growth
|
₹9,166 | 3.16% | -0.10% | 9.28% | 10.92% | 18.96% |
|
Nippon India Pharma Fund-Growth
|
₹9,166 | 3.09% | -0.31% | 8.81% | 9.96% | 17.90% |
|
Nippon India Pharma Fund-IDCW
|
₹9,166 | 3.09% | -0.31% | 8.81% | 9.96% | 17.90% |
|
Nippon India Nifty Pharma ETF-Growth
|
₹1,736 | 5.69% | 3.91% | 17.40% | 24.05% | 23.30% |
Nippon India Pharma Fund Direct-IDCW Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-Growth |
₹9,166 | ₹568.91 | 17.90% | 13.57% | 15.06% |
| Nippon India Pharma Fund Direct-Growth |
₹9,166 | ₹640.95 | 18.96% | 14.59% | 16.08% |
| Nippon India Pharma Fund-IDCW |
₹9,166 | ₹122.85 | 17.90% | 13.57% | 15.06% |
| Nippon India Pharma Fund Direct-IDCW |
₹9,166 | ₹175.42 | 18.96% | 14.59% | 16.08% |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹6,861 | ₹47.09 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund-Growth |
₹6,861 | ₹43.25 | 21.69% | 16.18% | - |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹6,861 | ₹26.43 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund-IDCW |
₹6,861 | ₹23.23 | 21.69% | 16.18% | - |
| SBI Healthcare Opportunities Fund-Growth |
₹5,870 | ₹522.56 | 24.17% | 18.45% | 14.48% |
| SBI Healthcare Opportunities Fund Direct Plan-Growth |
₹5,870 | ₹606.22 | 25.46% | 19.69% | 15.73% |
Nippon India Pharma Fund Direct-IDCW Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.37% | ₹1,172.29 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.85% | ₹1,158.46 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.78% | ₹1,155.93 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.78% | ₹1,155.93 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.78% | ₹1,155.93 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.78% | ₹1,155.93 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.35% | ₹1,152.63 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.55% | ₹1,145.91 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.92% | ₹1,099.37 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.08% | ₹1,086.73 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 13.02% | ₹1,075.90 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.71% | ₹1,072.95 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.71% | ₹1,072.95 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 11.71% | ₹1,072.95 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 12.22% | ₹1,067.77 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-Growth |
₹606.22 | 25.46% | 19.69% | - |
| SBI Healthcare Opportunities Fund Direct Plan-IDCW |
₹421.18 | 25.46% | 19.69% | - |
| SBI Healthcare Opportunities Fund-Growth |
₹522.56 | 24.17% | 18.45% | - |
| SBI Healthcare Opportunities Fund-IDCW |
₹329.19 | 24.17% | 18.45% | - |
| ICICI Prudential Healthcare Fund Direct-Growth |
₹47.09 | 22.70% | 17.19% | - |
| ICICI Prudential Healthcare Fund Direct-IDCW |
₹26.43 | 22.70% | 17.19% | - |
| Mirae Asset Healthcare Fund Direct-Growth |
₹53.16 | 24.58% | 17.02% | - |
| Mirae Asset Healthcare Fund Direct-IDCW |
₹32.02 | 24.58% | 17.02% | - |
| UTI Healthcare Fund Direct-Growth |
₹388.33 | 24.39% | 16.87% | - |
| UTI Healthcare Fund Direct-IDCW |
₹300.15 | 24.39% | 16.87% | - |
Frequently Asked Questions
Nippon India Pharma Fund Direct-IDCW
What is the current AUM of Nippon India Pharma Fund Direct-IDCW?
As of Wed Sep 30, 2026, Nippon India Pharma Fund Direct-IDCW manages assets worth ₹9,166.4 crore
How has Nippon India Pharma Fund Direct-IDCW performed recently?
- 3 Months: -0.10%
- 6 Months: 9.28%
What is the long-term performance of Nippon India Pharma Fund Direct-IDCW?
- 3 Years CAGR: 18.96%
- 5 Years CAGR: 14.59%
- Since Inception: 17.36%
What is the portfolio composition of Nippon India Pharma Fund Direct-IDCW?
Equity: 97.99%, Debt: 0.01%, Others: 2.00%.
Who manages Nippon India Pharma Fund Direct-IDCW?
Nippon India Pharma Fund Direct-IDCW is managed by Sailesh Raj Bhan from Nippon India Mutual Fund.
When was the last dividend declared by Nippon India Pharma Fund Direct-IDCW?
Latest dividend was declared on 06 Feb 2026 at 120.00% of face value.
What is the market-cap allocation of Nippon India Pharma Fund Direct-IDCW?
Large Cap: 30.53%, Mid Cap: 40.10%, Small Cap: 29.37%.
Which are the top companies Nippon India Pharma Fund Direct-IDCW has invested in?
- Sun Pharmaceutical Industries Ltd – 12.37% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.37% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.37% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.37% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 12.37% of the fund's portfolio
Which are the major sectors Nippon India Pharma Fund Direct-IDCW focuses on?
- Healthcare – 253.46% of the fund's portfolio




